The Integrated Microscopy Facility (IMF) functions as a supervised, user-based Core providing state-of-the-art microscopy imaging capabilities to University of Chicago Medicine Comprehensive Cancer Center (UCCCC) members and other University investigators. Light microscopy is an essential technology for cancer investigators. Modern microscopy enables observation of ever-finer detail, now breaking the optical diffraction barrier to yield super-resolution detail, thus providing information at scales ranging from tens of millimeters to less than 10 nanometers. The IMF offers all major wide-field and confocal techniques in addition to super- resolution technologies (e.g., stimulated emission depletion (STED), localization, structured light), and works to advance these methodologies for application to cancer research. Specific IMF developments in the current funding period include significant upgrades to microscope technologies and data analysis tools. Notably, these include installation of GSD super-resolution, a Lightsheet.z1 system, a SP8 white-light-laser spectral confocal, additional high-end workstations and upgrade to full-feature Imaris software. IMF staff additionally provides equipment maintenance, user training, and expert advice. Budgets reflect strictly a cost-recovery operation, with all services provided ?at-cost?. As an integrated Core, IMF allows for efficient pooling of resources and management, while creating a large user base that aids in leveraging support from the University as well as other agencies and keeping costs low. Half of the IMF usage is associated with research conducted by UCCCC members. Specifically, UCCCC labs are major users of the IMF; for any given service that approaches capacity usage, every effort is made to ensure priority access for UCCCC investigators. Institutional support mechanisms significantly enhance UCCCC research efforts within the IMF. The Biological Science Division (BSD) invested $1,001,408 in the Core in 2016 alone to purchase equipment requested by UCCCC members. The Core supported the work of 99 UCCCC investigators in the current funding period (2013-2016), which included 647 individual users of IMF services.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-45
Application #
9904509
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Zeineddine, Hussein A; Girard, Romuald; Saadat, Laleh et al. (2018) Phenotypic characterization of murine models of cerebral cavernous malformations. Lab Invest :
Kane, Melissa; Deiss, Felicity; Chervonsky, Alexander et al. (2018) A Single Locus Controls Interferon Gamma-Independent Antiretroviral Neutralizing Antibody Responses. J Virol 92:
Xiao, Annie; Crosby, Jennie; Malin, Martha et al. (2018) Single-institution report of setup margins of voluntary deep-inspiration breath-hold (DIBH) whole breast radiotherapy implemented with real-time surface imaging. J Appl Clin Med Phys 19:205-213
Gamazon, Eric R; Trendowski, Matthew R; Wen, Yujia et al. (2018) Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma. Sci Rep 8:733
Girard, Romuald; Zeineddine, Hussein A; Koskimäki, Janne et al. (2018) Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth. Circ Res 122:1716-1721
Day, Kasey J; Casler, Jason C; Glick, Benjamin S (2018) Budding Yeast Has a Minimal Endomembrane System. Dev Cell 44:56-72.e4
Pu, Jinyue; Kentala, Kaitlin; Dickinson, Bryan C (2018) Multidimensional Control of Cas9 by Evolved RNA Polymerase-Based Biosensors. ACS Chem Biol 13:431-437
Pectasides, Eirini; Stachler, Matthew D; Derks, Sarah et al. (2018) Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma. Cancer Discov 8:37-48
Liu, Hongtao; Zha, Yuanyuan; Choudhury, Noura et al. (2018) WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia. Exp Hematol Oncol 7:1
Nageeb, Shaheen; Vu, Milkie; Malik, Sana et al. (2018) Adapting a religious health fatalism measure for use in Muslim populations. PLoS One 13:e0206898

Showing the most recent 10 out of 668 publications